Pro-drug activation gene therapy using Herpes Simplex virus thymidine kinase (HSV-tk) gene transduction in combination with ganciclovir (GCV) is under investigation as a potential cancer therapy.
The Harvard Faculty of Arts and Sciences closed fiscal year 2024 with a $3 million surplus — its smallest surplus since 2020, the school announced last week in its annual financial report. The surplus ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results